| Primary |
| Product Used For Unknown Indication |
30.6% |
| Gastrooesophageal Reflux Disease |
20.5% |
| Hypertension |
7.9% |
| Dyspepsia |
6.8% |
| Drug Use For Unknown Indication |
6.0% |
| Prophylaxis |
2.7% |
| Hiatus Hernia |
2.6% |
| Gastritis |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Pain |
2.2% |
| Barrett's Oesophagus |
2.2% |
| Gastric Ulcer |
1.9% |
| Abdominal Pain Upper |
1.8% |
| Depression |
1.8% |
| Helicobacter Infection |
1.7% |
| Anxiety |
1.4% |
| Asthma |
1.3% |
| Reflux Oesophagitis |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Diabetes Mellitus |
1.2% |
|
| Hypomagnesaemia |
13.7% |
| Vomiting |
10.7% |
| Renal Failure Acute |
8.2% |
| Tubulointerstitial Nephritis |
7.5% |
| Product Substitution Issue |
7.0% |
| Drug Ineffective |
6.5% |
| Urticaria |
4.3% |
| Tetany |
4.1% |
| Weight Decreased |
4.0% |
| Drug Interaction |
3.8% |
| Hyponatraemia |
3.6% |
| Cutaneous Lupus Erythematosus |
3.2% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Rash |
3.0% |
| Rhabdomyolysis |
3.0% |
| Weight Increased |
3.0% |
| Nausea |
2.9% |
| Diarrhoea |
2.9% |
| Erectile Dysfunction |
2.9% |
| Paraesthesia |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
27.6% |
| Drug Use For Unknown Indication |
16.6% |
| Gastrooesophageal Reflux Disease |
16.6% |
| Hypertension |
8.3% |
| Pain |
4.6% |
| Depression |
3.2% |
| Prophylaxis |
2.4% |
| Dyspepsia |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Asthma |
2.0% |
| Anxiety |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Diabetes Mellitus |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Gastritis |
1.4% |
| Helicobacter Infection |
1.4% |
| Drug Abuse |
1.4% |
| Hiatus Hernia |
1.3% |
| Constipation |
1.1% |
| Barrett's Oesophagus |
1.1% |
|
| Tetany |
11.5% |
| Vomiting |
11.4% |
| Weight Decreased |
8.4% |
| Drug Ineffective |
6.9% |
| Toxic Epidermal Necrolysis |
6.9% |
| Weight Increased |
5.2% |
| White Blood Cell Count Increased |
4.5% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Off Label Use |
4.1% |
| Intentional Drug Misuse |
3.9% |
| Thrombocytopenia |
3.8% |
| Completed Suicide |
3.7% |
| Stevens-johnson Syndrome |
3.4% |
| Drug Dose Omission |
3.4% |
| Malaise |
3.3% |
| Rhabdomyolysis |
3.1% |
| Death |
3.1% |
| Hypomagnesaemia |
3.1% |
| Renal Failure Acute |
3.1% |
| Toxicity To Various Agents |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.3% |
| Drug Use For Unknown Indication |
16.3% |
| Hypertension |
8.2% |
| Rheumatoid Arthritis |
7.7% |
| Prophylaxis |
4.8% |
| Pain |
4.8% |
| Gastrooesophageal Reflux Disease |
3.3% |
| Depression |
2.9% |
| Diabetes Mellitus |
2.3% |
| Osteoporosis |
2.2% |
| Multiple Myeloma |
2.2% |
| Crohn's Disease |
2.0% |
| Blood Cholesterol Increased |
1.5% |
| Asthma |
1.5% |
| Anxiety |
1.5% |
| Atrial Fibrillation |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Hepatitis C |
1.3% |
| Insomnia |
1.2% |
| Nausea |
1.2% |
|
| Vomiting |
14.8% |
| Weight Decreased |
8.2% |
| Pneumonia |
5.6% |
| Weight Increased |
5.6% |
| Renal Failure Acute |
5.4% |
| Urinary Tract Infection |
5.4% |
| Pyrexia |
5.2% |
| Death |
5.1% |
| Thrombocytopenia |
4.5% |
| Nausea |
4.5% |
| Pain |
4.5% |
| Drug Ineffective |
4.1% |
| Sepsis |
3.7% |
| Dyspnoea |
3.5% |
| Tremor |
3.5% |
| Rash |
3.4% |
| Renal Failure |
3.4% |
| Pulmonary Embolism |
3.3% |
| Myocardial Infarction |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
27.8% |
| Drug Use For Unknown Indication |
14.3% |
| Hypertension |
8.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.7% |
| Dyspepsia |
4.4% |
| Pain |
4.4% |
| Depression |
3.6% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Bone Pain |
3.4% |
| Osteoporosis |
3.4% |
| Epilepsy |
3.3% |
| Constipation |
2.3% |
| Hyperlipidaemia |
2.2% |
| Cardiac Disorder |
2.1% |
| Helicobacter Infection |
2.1% |
| Prophylaxis |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Thrombosis Prophylaxis |
2.1% |
| Chemotherapy |
2.0% |
| Atrial Fibrillation |
1.8% |
|
| Drug Interaction |
30.5% |
| Tremor |
8.0% |
| Hypertension |
6.4% |
| Vomiting |
5.9% |
| Toxicity To Various Agents |
4.8% |
| Respiratory Tract Congestion |
4.3% |
| Transaminases Increased |
4.3% |
| Hyponatraemia |
3.7% |
| Thrombocythaemia |
3.7% |
| Polymyositis |
3.2% |
| Renal Tubular Acidosis |
3.2% |
| Rhabdomyolysis |
3.2% |
| Therapeutic Agent Toxicity |
3.2% |
| Drug Resistance |
2.7% |
| Pyrexia |
2.7% |
| Potentiating Drug Interaction |
2.1% |
| Supraventricular Tachycardia |
2.1% |
| Vestibular Disorder |
2.1% |
| Weight Increased |
2.1% |
| Coagulopathy |
1.6% |
|
